Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology

BERLIN & BRISBANE, Calif.--(BUSINESS WIRE)-- #Bayer--Mammoth Biosciences partners with Bayer to develop gene-editing therapies for five in vivo indications, first focusing on liver-targeted diseases.

Click to view original post